Patents A Key Focus As Drug-Pricing Debate Intensifies | Cadwalader

Skip to Main Content

News : Recent Press

Intellectual Property special counsel Danielle Tully shares her insights on lawmakers’ interest in how pharmaceutical patents impact drug prices, and comments on the potential benefits of one legislative proposal.

Read the article here.

Credit Risk Transfers (CRTs): A Handbook for U.S. Banks

CFPB's Google Fight Threatens Power to Designate Risky Companies

CMBS Lending Is Higher Than It's Been in Years

Bitcoin Is Surging, and the IRS Is Watching Closer Than Ever

Faster FCA Investigations Can Protect Suspects’ Wellbeing

Cadwalader Represents ATIC in Landmark Insurance Fraud Lawsuit

Cadwalader Advising Guardian in High-Profile Wendy Williams Litigation

_____________________________________________

Cadwalader Named to GIR 100 2024

Cadwalader Once Again Shortlisted for ‘Law Firm of the Year' Award

Cadwalader Lawyers Named as 2025 Lawdragon 500 Leading Dealmakers in America

Cadwalader Partners Named to Benchmark Litigation 2025

Cadwalader Earns 2023-2024 Mansfield Certification in Continued Commitment to Diversity